Clinical trial
Observational Study to Evaluate the Effectiveness, Immunogenicity and Safety of Inactivated COVID-19 Vaccine (TURKOVAC) Application
NCT05863429 is registered in ClinicalTrials.gov with Health Institutes of Turkey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study to Evaluate the Effectiveness, Immunogenicity and Safety of Inactivated COVID-19 Vaccine (TURKOVAC) Application
- Lead sponsor
- Health Institutes of Turkey
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 18, 2022
- Completion date
- April 1, 2024
- Enrollment
- 200 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 infection